000566 Hainan Haiyao
- 4.08
- +0.37+9.97%
About Hainan Haiyao Company
The company's predecessor, Haikou Pharmaceutical Factory, was founded in 1965 and listed on the Shenzhen Stock Exchange in 1994. It is a leading enterprise in the pharmaceutical industry in Hainan Province. On March 24, 2020, Xinxing Jihua Pharmaceutical and Hainan Haiyao completed a strategic restructuring. Xinhai Pharmaceutical became a mixed ownership enterprise controlled by a central enterprise, beginning a new journey of Haiyao development. The company's main business is R&D, production and sales of antibiotic series, gastrointestinal medicine series, antineoplastic drug series, raw materials and intermediates supporting preparations, and other products. The company's main products throughout the year include the following series, which are antibiotics series, gastrointestinal medicine series, antineoplastic drug series, raw materials and intermediates supporting the formulation, and other products. Company Honors: High-tech Enterprise in Hainan Province; Vice Chairman's Unit; Top 50 Industrial Enterprises in Hainan; Top Ten Tax-Paying Enterprises, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- jianping wang
- Chairman, Directors, Nomination Committee Members, Strategy Committee Convener
- --
- chang liu
- Directors
- --
- duojia feng
- Directors, Member of the Remuneration and Assessment Committee, Audit Committee Member
- --
- junhong wang
- Directors, General Manager, Nomination Committee Members, Member of the Remuneration and Assessment Committee
- 665.10K
- yuexiang zhao
- Directors, Member of the Strategy Committee
- 267.70K
- xiuqun hu
- Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee, Nomination Committee Members
- 100.00K
- tao lu
- Independent Directors, Nomination Committee Convener, Strategy Committee Members, Remuneration and Assessment Committee Members, Audit Committee Members
- --
- yulin wei
- Independent Directors, Nomination Committee Members, Audit Committee Member, Remuneration and Assessment Committee Convener, Member of the Strategy Committee
- 200.00K
- lei shi
- Board Secretary, Deputy General Manager
- 607.40K
- xiaosu wang
- Securities Affairs Representative
- --
- zengfu zhang
- Chairman of the Supervisory Board, Auditors
- --
- yadong zhou
- Auditors
- --
- hui zhang
- Deputy General Manager
- 515.40K
- rongyi xu
- Head of Finance
- 642.20K
- haifeng yin
- Chief Engineer
- 1.11M
- jianpeng wang
- Sales Director
- 448.40K
- shuxiong han
- Employee Supervisors
- 158.10K
Analysis
Price Target
No Data
